Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique
Reprod. health; 12 (112), 2015
Background: A major unresolved safety concern for malaria case management is the use of artemisinin combination therapies (ACTs) in the first trimester of pregnancy. There is a need for human data to inform policy makers and treatment guidelines on the safety of artemisinin combination therapies (ACT) wh...
Antimalarials/adverse effects, Artemisinins/adverse effects, Clinical Protocols, Cohort Studies, Drug Administration Schedule, Gestational Age, Malaria/therapy, Maternal-Fetal Exchange, Patient Selection, Pharmacovigilance, Pregnancy Complications, Parasitic/therapy, Pregnancy Outcome, Pregnancy Trimester, First, Prenatal Exposure Delayed Effects, Prospective Studies, Research Design, Sample Size, Mozambique, Burkina Faso, Kenya, Antimalarials/therapeutic use, Artemisinins/therapeutic use